Summary of Efficacy Findings in Unpublished/Published Reports of Clinical Studies Related to the Use of ESWT in Wound Treatment |
Author | Treatment (Device) | Dose | N (Wound Type) | Follow‑Up Time | Efficacy Variable |
Kamelger | ESWT w/EvoTron™ 4 Treatments | 500 (0.11 mJ/mm2) | 9 (diabetes-related chronic leg ulcers | 27 days 62 days | >92% wound closure 5/9 6/9 |
Schaden (2007) | ESWT w/EvoTron™ 1-10 Treatments | Total of 250 – 6900 impulses; mean of 1764; 0.1 mJ/mm2 | 27 (wounds) | NR | Dropped out 4 (6.8) Completed study 23/27 (85.2%) Full wound closure 22 (95.7%) 50% epithelialization 1 (4.3%) |
Medical University Of Innsbruck, Plastic Surgery | ESWT with EvoTron+ split skin grafting 1-2 treatments | 500 shocks per treatment at 0.07-0.1 mJ/mm2 | 19 (arterial and venous ulcers) | NR | Graft uptake complete 16/19 (84.2%) Graft uptake incomplete 3/19 (15.8%) |
ESWT with EvoTron™ 4 Treatments | 14 (diabetic ulcers) | NR | Complete healing 10/14 (71.4%) Incomplete healing 4/14 (28.6%) |
ESWT with EvoTron™ 1 Treatment | 5 (deep partial thickness burns) | NR | Complete healing 5/5 (100%) |
Wang (2007) | dermaPACE™ 6 Treatments (2 series in some cases) | 500 (0.11 mJ/mm2) | 42 (diabetic ulcers) > 3 Months | Closure | Complete healing 22/42 (55%) >50% improved 18/42 (43%) No change 2/42 (5%) |
Van Acker | dermaPACE™ 4 Treatments * 3 patients (6x) | 500 PACE™ pulses per treatment | 12 (diabetic food ulcers) > 3 months | Closure ≤ 12 weeks | Complete healing 9/12 (75%) >50% improved 2/12 (17%) No change 1/12 (8%) |
Saggini | ESWT with EvoTron™ 6 Treatments | 100 impulses per cm2 | 32 (chronic posttraumatic, diabetic and/or venous wounds) | Closure | Complete healing 16/32 (50%) Some closure, granulation and decreased exudates 16/32 (50%) |
Moiemen (2008) | dermaPACE™ 2 Treatments | 8 impulses per cm2 | 10 (mid-deep dermal burns) | Closure | Complete healing 10/10 (100%) No grafting |
Barret (2010) | dermaPACE™ 2 Treatments | 8 impulses per cm2 | 15 (type II and III mixed deep partial to full thickness burns) | Closure | Complete healing 12/15 (80%) No grafting Incomplete healing 2/15 (13%) 1 patient lost to follow up |